ALEXANDER MARGARET A. — SEC Form 4 filings

SEC reporting owner CIK 2036798. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-02.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-09-11 to 2026-03-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Ovid Therapeutics Inc. (OVID)President and CEO, Director61 leg · 6,810 sh · $4,9712 legs · 16,935 sh · $19,8575

Form 4 filings — ALEXANDER MARGARET A.

FiledFormIssuerReported transactionsSource
2026-03-024Ovid Therapeutics Inc. (OVID)Sale (S): 11,656 @ $1.45 · Grant/award (A): 1,435,000 (derivative) @ $0EDGAR
2026-01-054Ovid Therapeutics Inc. (OVID)Grant/award (A): 890,000 (derivative) @ $0EDGAR
2025-02-284Ovid Therapeutics Inc. (OVID)Sale (S): 5,279 @ $0.56EDGAR
2025-02-244Ovid Therapeutics Inc. (OVID)Grant/award (A): 43,750 @ $0 · Grant/award (A): 262,500 (derivative) @ $0EDGAR
2025-01-294Ovid Therapeutics Inc. (OVID)Purchase (P): 6,810 @ $0.73EDGAR
2024-09-114Ovid Therapeutics Inc. (OVID)Grant/award (A): 140,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2036798 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →